The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.1099G>C (p.Gly367Arg)

CA410148133

2126320 (ClinVar)

Gene: RUNX1 (HGNC:861)
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome (MONDO:0011071)
Inheritance Mode: Autosomal dominant inheritance
UUID: 7279e349-fac0-40be-9caf-43641b65ce38
Approved on: 2024-08-01
Published on: 2024-08-01

HGVS expressions

NM_001754.5:c.1099G>C
NM_001754.5(RUNX1):c.1099G>C (p.Gly367Arg)
NC_000021.9:g.34792479C>G
CM000683.2:g.34792479C>G
NC_000021.8:g.36164776C>G
CM000683.1:g.36164776C>G
NC_000021.7:g.35086646C>G
NG_011402.2:g.1197233G>C
ENST00000675419.1:c.1099G>C
ENST00000300305.7:c.1099G>C
ENST00000344691.8:c.1018G>C
ENST00000399240.5:c.826G>C
ENST00000437180.5:c.1099G>C
ENST00000482318.5:c.*689G>C
NM_001001890.2:c.1018G>C
NM_001754.4:c.1099G>C
NM_001001890.3:c.1018G>C
More

Uncertain Significance

Met criteria codes 1
PM2_Supporting
Not Met criteria codes 18
PS2 PS4 PS3 PS1 PP1 PP3 PM6 PM1 PM4 PM5 PVS1 BA1 BS4 BS3 BS1 BP7 BP2 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.1099G>C (p.Gly367Arg) is a missense variant which is completely absent from all population databases (gnomAD v2.1.1 and v3.1.2) with at least 20x coverage for RUNX1 (PM2_supporting). It has a REVEL score of 0.707, which does not allow applying either PP3 (>0.88) or BP4 (<0.50). Additionally, there is no previous report of this variant. In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is completely absent from all population databases (gnomAD v2.1.1 and v3.1.2) with at least 20x coverage for RUNX1 (PM2_supporting).
Not Met criteria codes
PS2
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PS4
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PS3
To our knowledge, no in vitro or in vivo functional studies are available for this variant.
PS1
This rule cannot be applied because, to our knowledge, this missense variant does not generate the same amino acid change as a previously identified pathogenic variant regardless of nucleotide change.
PP1
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study and we have no information about its cosegregation with the disease.
PP3
This rule cannot be applied since this missense variant has not a REVEL score >0.88 (0.707).
PM6
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PM1
This rule cannot be applied since this missense variant affects amino acid residue 367, which is out of RHD or residues 89-204.
PM4
This rule cannot be applied since this is a missense variant.
PM5
This rule cannot be applied because, to our knowledge, this missense variant does not impact an amino acid residue where a different pathogenic missense change has previously been observed.
PVS1
This rule cannot be applied since this is a missense variant.
BA1
This rule cannot be applied since the variant is completely absent from all population databases.
BS4
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study and we have no information about segregation.
BS3
To our knowledge, no in vitro or in vivo functional studies are available for this variant.
BS1
This rule cannot be applied since the variant is completely absent from all population databases.
BP7
This rule cannot be applied since this is a missense variant.
BP2
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
BP4
This rule cannot be applied since this missense variant has not a REVEL score <0.50 (0.707).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.